Search alternatives:
significantly smaller » significantly higher (Expand Search), significantly lower (Expand Search), significantly better (Expand Search)
significantly greater » significantly correlated (Expand Search), significantly increased (Expand Search), significantly higher (Expand Search)
smaller decrease » small decrease (Expand Search), marked decrease (Expand Search), smaller areas (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
significantly smaller » significantly higher (Expand Search), significantly lower (Expand Search), significantly better (Expand Search)
significantly greater » significantly correlated (Expand Search), significantly increased (Expand Search), significantly higher (Expand Search)
smaller decrease » small decrease (Expand Search), marked decrease (Expand Search), smaller areas (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
-
461
-
462
-
463
-
464
Data Sheet 1_Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greate...
Published 2025“…Background<p>Multiple myeloma (MM) is a plasma cell malignancy with significant unmet medical needs, particularly in the treatment of relapsed and refractory disease. …”
-
465
Study selection criteria.
Published 2025“…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …”
-
466
PICOS criteria for the SLR.
Published 2025“…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …”
-
467
PRISMA flow chart.
Published 2025“…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …”
-
468
-
469
Flowchart of the study.
Published 2024“…At species level, <i>Schaalia</i> spp., <i>Streptococcus gordonii</i>, and <i>Leptotrichia wadei</i> increased in Placebo and decreased in the Probiotic group after treatment. <i>Granulicatella adiacens</i> decreased significantly after the probiotic therapy, while <i>Saccharibacteria</i> (TM7) spp., <i>Solobacterium moorei</i>, and <i>Catonella morbi</i> increased significantly. …”
-
470
-
471
-
472
-
473
-
474
-
475
-
476
-
477
-
478
-
479
-
480